Aligos Therapeutics, Inc. (ALGS) vs BeyondSpring Inc. (BYSI)

A side-by-side comparison of Aligos Therapeutics, Inc. and BeyondSpring Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — ALGS vs BYSI

growth of $100 · dividends reinvested · last 6y
ALGS -98.5% (-50.6%/yr)BYSI -94.8% (-39.0%/yr)BYSI compounded faster over this window
050100150200250Start $100202120222023202420252026$1$5
ALGS BYSI

ALGS vs BYSI: by the numbers

  • •ALGS is the larger company ($33M vs $31M market cap).
  • •Both run net losses; BYSI's is the smaller (0.00% vs -241.01% net margin).

Metrics side by side

Valuation

MetricALGSBYSI
P/S ratio1.03N/A
P/B ratio1.02N/A

Profitability

MetricALGSBYSI
Gross margin57.46%0.00%
Operating margin-4024.93%0.00%
Net margin-241.01%0.00%
ROE-238.24%N/A
ROIC-207.97%N/A

Growth (annualized)

MetricALGSBYSI
Revenue CAGR (5Y)-15.85%N/A
Total return CAGR (5Y)-57.15%-44.30%

Frequently asked

How have ALGS and BYSI total returns compared?
Over the past 5 years, ALGS delivered -57.15% and BYSI delivered -44.30% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.